BIOMARIN PHARMACEUTICAL INC (BMRN) Form 8-K — Sep 14, 2026
BioMarin Pharmaceutical appointed Robert Plenge, M.D., Ph.D., to its Board of Directors effective September 10, 2026, expanding the board from ten to eleven members. The filing states he was not selected pursuant to any arrangement or understanding with any person. Dr. Plenge also joined the board's Science and Technology Committee and will receive the standard fees paid to non-employee directors and committee members.
Key figures
- Board size before
- 10
- Rsu grant value usd
- 400000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.